|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2020 2:17:31 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, all provisions
H.R. 6201, Families First Coronavirus Response Act, all provisions
H.R. 6379, Take Responsibility for Workers and Families Act, all provisions
H.R. 266, Paycheck Protection Program and Health Care Enhancement Act, all provisions
H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act, all provisions
H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, provisions related to physician office stability and public health
H.R. 1425, Patient Protection and Affordable Care Enhancement Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1763, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 5654, Expanding Medical Education Act of 2020, all provisions
H.R. 6090, Physician Shortage GME Cap Flex Act of 2020, all provision
H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1503, Orange Book Transparency Act of 2019, all provisions
H.R. 1520, Purple Book Continuity Act of 2019, all provisions
H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions
H.R. 6644, Health Care at Home Act of 2020, all provisions
S. 3741, Health Care at Home Act of 2020, all provisions
H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions
H.R. 3630, No Surprises Act, all provisions
S. 1531, Stopping The Outrageous Practice of (STOP) Surprise Medical Bills Act of 2019, all provisions
H.R. 4995, Maternal Health Quality Improvement Act of 2019, all provisions
S. 3749, Public Health Emergency Privacy Act, all provisions
S. 3861, Exposure Notification Privacy Act, all provisions
H.R. 6585, Equitable Data Collection and Disclosure on COVID-19 Act, all provisions
H.R. 7255, To authorize the Secretary of Health and Human Services to award grants to health care providers to establish or expand programs dedicated to promoting mental wellness among their health care workers, including contractors, on the front lines of the SARS-CoV-2 pandemic, and for other purposes, all provisions
H.R. 7120, George Floyd Justice in Policing Act of 2020, all provisions
H.R. 7154, Outpatient Therapy Modernization and Stabilization Act, all provisions
H.R. 2279, Safe Step Act, all provisions
H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 1895, Lower Health Care Costs Act, provisions relating to surprise billing
H.R. 5826, Consumer Protections Against Surprise Medical Bills Act of 2020, all provisions
H.R. 4379, Under Performing Directories that Affect Treating Emergencies (UPDATE) Act, all provisions
H.R. 4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019, all provisions
H.R. 2482, Mainstreaming Addiction Treatment (MAT) Act of 2019, all provisions
COVID-19/Testing and contact tracing funding/national testing strategy/serology testing
COVID-19/National supply chain strategy
COVID-19/Data on race, ethnicity, and preferred language
COVID-19/Controlled Substances/increased production/prescribing flexibility
COVID-19/Physician employment/financial relief
COVID-19/Inmates and staff hygienic conditions/health literacy
COVID-19/World Health Organization (WHO)/International Classification of Diseases
Public Health and Social Services Emergency Fund/provider relief
Affordable Care Act stabilization
Pharmacy Benefits Manager (PBM)
Opioids/pain management
Opioids Use Disorder/Medication-assisted treatment (MAT)
Opioid Treatment Programs (OTPs)/COVID-19 telemedicine flexibility
Narcotic treatment programs/mobile components
21st Century Cures Act
42 CFR Part 2, HIPAA
Telehealth waivers
Surprise billing
Expanded personal protective equipment (PPE)/clearinghouses
Expansion of Paycheck Protection Program
Health Disparities
Pandemic planning and preparedness
Resident physicians and students support
Prescription drug pricing/transparency/value
Prior authorization
Health equity
Physician burnout/suicide
Kidney transplantation/regulatory policies
Cybersecurity
Electronic health record (EHR) certification
Electronic Prescribing for Controlled Substances (EPCS)/biometric technology
Defense Production Act
Augmented Intelligence (AI)/federal regulation of applications
K-12 Health curriculum (including nutrition)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Drug Enforcement Administration (DEA), President of the U.S., Vice President of the U.S., Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), White House Office, Centers For Disease Control & Prevention (CDC), Office of Natl Drug Control Policy (NDCP), Federal Bureau of Prisons (BOP), Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
|
Danielle |
Turnipseed |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 6788, Healthcare Workforce Resilience Act, all provisions
S. 3599, Healthcare Workforce Resilience Act, all provisions
International Medical Graduates (IMGs)/work permits
IMGs/60-day grace period extension
H-4 Visa extensions
J-1, H-1B, and O-1 IMG exemptions/COVID-19
J-1 and H-1B Visa/Presidential Proclamation waiver
Pregnant asylum seekers/access to health care/ Customs and Border Protection (CBP) oversight
DACA
Immigration/Binary Choice
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Vice President of the U.S., U.S. Citizenship & Immigration Services (USCIS), State - Dept of (DOS), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in health insurance
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1301, Mental Health Telemedicine Expansion Act, all provisions
H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act of 2019, all provisions
H.R. 5201, Telemental Health Expansion Act of 2019, provisions relating to 1834(m) of the Social Security Act; geographic and originating sites
H.R. 7233, To direct the Secretary of Health and Human Services and the Comptroller General of the United States to conduct studies and report to Congress on actions taken to expand access to telehealth services under the Medicare, Medicaid, and Children's Health Insurance programs during the COVID-19 emergency, all provisions
H.R. 4996, Helping Medicaid Offer Maternity Services Act of 2019, all provisions
H.R. 6837, Medicare Accelerated and Advance Payments Improvement Act of 2020, all provisions
S. 3750, Medicare Accelerated and Advance Payments Improvement Act, all provisions
H.R. 6585, Equitable Data Collection and Disclosure on COVID-19 Act, all provisions
H.R. 19, Lower Costs, More Cures Act of 2019, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions
H.R. 4004, Social Determinants Accelerator Act of 2019, all provisions
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions
H.R. 884, Medicare Mental Health Access Act, all provisions
H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
H.R. 3414, Opioid Workforce Act of 2019, all provisions
H.R. 5741, Strengthening Innovation in Medicare and Medicaid Act, all provisions
Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020
Medicare program: Medicare for All
Medicare program: Interoperability and data blocking
Medicare program: Payment and delivery reform
Medicare program: Accountable Care Organizations/COVID-19
Medicare program: Evaluation and Management (E&M)/Budget neutrality
Medicare program: Graduate Medical Education (GME)
Medicare program: Advanced Alternative Payment Models (APMs)
Medicare program: Physician-focused APMs
Medicare program: Prior Authorization/Utilization Management
Medicare program: Scope of practice
Medicare program: Inpatient Rehabilitation Facility (IRF) coverage
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: MIPS flexibility and hardship exemptions
Medicare program: MIPS Value Pathways (MVPs)
Medicare program: PECOS Enrollment/Revalidation
Medicare program: Autopsy standard/condition of participation
Medicare program: Benefit Category Definition (BCD)/power wheelchair features/DME
Medicare program: MACRA Cost Measure Development
Medicare program: Diabetes prevention
Medicare program: Open Payments
Medicare program: Accelerated and Advance Payment Program
Medicare and Medicaid programs: Contract Year 2021 and 2022 Policy and Technical Changes
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
Medicare and Medicaid programs: Patient Protection and Affordable Care Act/interoperability/patient access for Medicare Advantage/Medicaid Managed Care/Exchanges
Medicare and Medicaid programs: Health IT Certification program
Medicare and Medicaid programs: Health data and privacy
Medicare and Medicaid programs: Opioid legislation implementation
Medicare and Medicaid programs: Telehealth waivers
Medicare and Medicaid programs: COVID-19 laboratory developed tests/coverage
Medicare and Medicaid programs: COVID-19/Payment policy changes/regulatory flexibilities
Medicare and Medicaid programs: Public Health Services Emergency Funding/provider relief
Medicaid program: Federal Medical Assistance Percentage (FMAP)
Medicaid program: Child Health Insurance Program (CHIP)
Medicaid program: Maternal health
Medicaid program: Provider advance payments
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
|
Danielle |
Turnipseed |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax treatment of federal COVID-19 relief payments
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 7059, Coronavirus Provider Protection Act, all provisions
Good Samaritan Health Professionals Act
Medical liability
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Scope of practice/Directive 1899
Veterans Choice/Community Care Program
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
COVID-19 funding
COVID-19/Disproportionate effect
Maternal morbidity
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Dana |
Lichtenberg |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |